What roles and responsibilities do Clinical Pharmacists have in the NHS? How can Pharma and Medtech engage Clinical Pharmacists, and how can industry best support these new decision-makers? Tom Clarke (Director, Mtech Access) explores all this and more with Tom Kallis (Senior Clinical Pharmacist, East Cornwall PCN). They explore the origins of the Clinical Pharmacist role and how it has become a key part of the primary care landscape, to understand how the responsibilities of those in the...

As the NHS takes steps towards a more integrated future, how are systems and care pathways transforming? How is change being implemented, and what does this look like in reality for local systems and populations? Tom Clarke (Director, Mtech Access) explores all this and more with Debbie Morgan, (Director of Service Improvement and Transformation, Cambridge University Hospitals NHS Foundation Trust). Learn more about this webinar at...

Our experts in health economics, value communication, design and digital discuss how to craft digital payer value communication tools to meet the needs of internal stakeholders, including market access teams and KAMs, and healthcare customers. What does a best-in-class value communication tool look like in 2022? What are the key considerations when developing a new payer value toolkit? And what should Pharma and Medtech companies look for in a consultancy partner? For this webinar we...

What does population health management mean for the NHS, for patients, and for industry? How will the NHS translate population health management into impactful service change and what will this look like for patients? Tom Clarke (Director, Mtech Access) explores all this and more with guest speaker Dr Steven Laitner (GP, Parkbury House Surgery). Steven and Tom explore how the NHS can translate the theory of population health management into practical service changes that improve care for...

What does the ‘2022/23 priorities and operational planning guidance’ document mean for the NHS, for Integrated Care System (ICS) development and for an NHS workforce still battling COVID? How realistic and achievable are the priorities set out, and how can Pharma and Medtech best help NHS leaders to achieve these goals? Caroline Dawe (Deputy Director of Commissioning, Bristol, North Somerset and South Gloucestershire Clinical Commissioning Group [CCG]) joins Tom Clarke (Director, Mtech...

Pharma and Medtech professionals put questions to our panel of NHS associates as we reflected on the operational, structural, and clinical challenges the NHS has faced in 2021 and how Pharma and Medtech can best support the NHS in 2022. We were joined by some of Mtech Access’s closest and most insightful friends: - David Thorne (Director, Mtech Access and Well Up North PCN) our Policy expert - Patrick McGinley (Head of Costing and Service Line Reporting, Maidstone and Tunbridge Wells NHS...

How will medicines be valued in the newly integrated world of the NHS? What are the risks and benefits of a single national formulary? What else is changing? And what does this mean for market access? Ellen Rule (Programme Director of the Gloucestershire Integrated Care System [ICS] and Director of Transformation and Service Redesign, Gloucestershire Clinical Commissioning Group [CCG]) joins Tom Clarke (Director, Mtech Access) to explore all this and more. Tom Clarke and Ellen Rule discuss...

We explore the challenges facing orphan medicines and other innovative rare disease treatments looking to achieve market access in Europe. Orphan medicines and rare disease treatments are faced with a complex, ever-changing market landscape. These treatments also face unique tactical challenges on the route to securing market access. Here we bring together specialists from our global market access (Rob Taaffe), systematic review (Regina Leadley), and health economic (Calum Jones) teams to...

How are healthcare systems looking differently at their population to deliver better care and what does this mean for future decision-making? How might the NHS re-imagine the hospital? What benefits can we expect from novel technologies, and can the NHS develop system resilience to improve healthcare outcomes? Dr Phil Webb (Chief Executive of Respiratory Innovation Wales) joined Tom Clarke (Director, Mtech Access) to explore all this and more. Re-imagining the hospital, investing in novel...

How can the NHS address health inequalities through innovation? How can new health technologies help improve population health? How can Pharma, Medtech and the wider life sciences industry support the NHS with these goals? And what does the NHS’ ambitions in this area mean for your market access strategy? Jon Siddall (Chief Executive of the South West Academic Health Science Network [AHSN]) joins Tom Clarke (Director, Mtech Access) to explore these questions and more. Before joining the...

What role do Ambulance Trusts play in the success of the wider NHS? How might urgent and community care evolve as we head to integration as part of a joined-up system? How will an integrated ambulance service support system redesign to keep people out of hospital, and provide more proactive care to those who need it most? Helen Ray (Chief Executive of North East Ambulance Service NHS Foundation Trust) joins  Tom Clarke (Director, Mtech Access) to discuss the role Ambulance Trusts play in...

Population health management is often talked about in top-down terms, but how seriously will the needs of individuals be taken as systems develop? How will personal needs inform care delivery? Why will the patient voice play a very different role in the NHS of the future? Steph Edusei (Chief Executive of St Oswald’s Hospice) joins Tom Clarke (Director, Mtech Access) to explore these questions and more.  This episode was first released as a live webinar on Friday 21st May 2021. For more...

What will a ‘Place’ look like? What will this new layer of the NHS mean in practice and what decision-making powers will Place leaders have? As the NHS starts its journey towards an integrated future, Dr Steven Michael OBE (Chair of East Cheshire Partnership) joins Tom Clarke (Director, Mtech Access)  to talk ‘Place’, ‘Partnership’, ’Collaboratives’ and more. The UK Government’s Health and Care White Paper, along with other recent policy announcements, set out a major proposed reorganisation...

Mtech Access Health Economists, Calum Jones and Nick Swart, discuss what, why and how health economic models can support MedTech innovations to demonstrate value, achieve market access and reach more patients.

Professor Inderjit Singh (Chief Pharmacist at University Hospitals Birmingham) joins Tom Clarke (Director, Mtech Access) to explore the changes we can expect to pharmacy, medicines management, and specialised commissioning in the new NHS

Are you wondering what integrated care will look like when the Health and Care White Paper proposals become a reality? Tom Clarke interviews Dr John Ribchester about what the proposals means in practice for clinicians, for patients and for the life sciences industry.

With mental health services facing unique challenges, Brent Kilmurray (Chief Executive of Tees, Esk and Wear Valleys NHS Foundation Trust), joins Tom Clarke (Director, Mtech Access) to explore the challenges of leading mental health services in the NHS.

With new policy passing power to Integrated Care Systems (ICS), we explore how pharmacy and medicines commissioning will work in the new system, with Laura Angus (Interim Lead Pharmacist, Humber, Coast and Vale ICS)

Dr Peter Brambleby (Independent Public Health Consultant) joins Tom Clarke (Director, Mtech Access) to discuss the role public health has played through the COVID pandemic and its importance to the population going forward.

Simon Parsons (Divisional Director of Surgery at Nottingham University Hospitals NHS Trust) joins Tom Clarke (Director, Mtech Access) to discuss how decisions, such as the postponement of non-urgent elective surgery, are made, the impact this has on patients and staff, and how the NHS might adapt to provide care for these patients.

Discover what it’s like to be a leader in today’s NHS and how industry can best support NHS leaders. Deborah Lee (Chief Executive of Gloucestershire Hospitals NHS Trust) speaks to David Thorne (Director, Mtech Access) about how she and her colleagues are responding to the challenges presented by the COVID-19 pandemic, the resultant backlog in care, and the latest policy changes.

Dr Claire Fuller (Senior Responsible Officer at Surrey Heartlands Health and Care Partnership) join Tom Clarke (Director, Mtech Access) to discuss the evolving world of Integrated Care Systems (ICS).

Tom Clarke and David Thorne, from the Mtech Access NHS Insights & Interaction team, review some of the insights from our earlier series: ‘How is COVID-19 impacting the NHS?’, as well as exploring trends and challenges uncovered in conversation with our network of NHS Associates. From capacity management to changing performance measures, listen to discover what’s changing in the NHS, the impact on the NHS long-term plan and what all this means for the future of market access.

We are joined by Jim Easton (CEO of Care UK) to discuss the role of the independent sector in supporting the NHS and the wider care industry, both during the pandemic and in a post-COVID world.

We explore a different aspect of the COVID response, speaking with Stephen Bourke (Co-Founder of Echo), to learn how Echo and other tech companies have been supporting patients with new ways of accessing healthcare, throughout lockdown.